Dafei Chai

1.9k total citations · 2 hit papers
56 papers, 1.4k citations indexed

About

Dafei Chai is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Dafei Chai has authored 56 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 32 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in Dafei Chai's work include Immunotherapy and Immune Responses (23 papers), CAR-T cell therapy research (17 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Dafei Chai is often cited by papers focused on Immunotherapy and Immune Responses (23 papers), CAR-T cell therapy research (17 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Dafei Chai collaborates with scholars based in China, United States and Italy. Dafei Chai's co-authors include Nan Bai, Beibei Liang, Yun Cai, Junnian Zheng, Huizhong Li, Gang Wang, Navid Sobhani, Junnian Zheng, Praveen Neeli and Jin Bai and has published in prestigious journals such as Blood, Frontiers in Immunology and Experimental Cell Research.

In The Last Decade

Dafei Chai

55 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

2012 453 citations Dafei Chai et al. profile →
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects

2024 69 citations Bowen Lu, Siyuan Song et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dafei Chai China	17	562	432	412	343	160	56	1.4k
Yaomei Tian China	20	831 1.5×	409 0.9×	193 0.5×	294 0.9×	68 0.4×	36	1.5k
Chris Parsons United States	24	678 1.2×	242 0.6×	204 0.5×	438 1.3×	58 0.4×	40	1.3k
Philippe Lehours France	27	494 0.9×	506 1.2×	111 0.3×	246 0.7×	44 0.3×	68	2.4k
Yajie Zhao China	14	233 0.4×	122 0.3×	249 0.6×	109 0.3×	64 0.4×	38	685
Carina Vingsbo Lundberg Denmark	20	402 0.7×	621 1.4×	165 0.4×	123 0.4×	121 0.8×	38	1.4k
Sonia Gómez Argentina	21	248 0.4×	378 0.9×	403 1.0×	56 0.2×	97 0.6×	59	1.1k
Brandon Tan United States	14	432 0.8×	237 0.5×	244 0.6×	139 0.4×	27 0.2×	21	902
Simo Huang United States	19	740 1.3×	115 0.3×	118 0.3×	148 0.4×	145 0.9×	44	1.4k
Julie Segre United States	7	430 0.8×	143 0.3×	387 0.9×	33 0.1×	120 0.8×	13	1.1k
Wenjing Wu China	19	504 0.9×	53 0.1×	554 1.3×	71 0.2×	121 0.8×	42	1.2k

Countries citing papers authored by Dafei Chai

Since Specialization

Citations

This map shows the geographic impact of Dafei Chai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dafei Chai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dafei Chai more than expected).

Fields of papers citing papers by Dafei Chai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dafei Chai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dafei Chai. The network helps show where Dafei Chai may publish in the future.

Co-authorship network of co-authors of Dafei Chai

This figure shows the co-authorship network connecting the top 25 collaborators of Dafei Chai. A scholar is included among the top collaborators of Dafei Chai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dafei Chai. Dafei Chai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chai, Dafei, Junhao Wang, Xiaohui Xie, et al.. (2025). Lipid nanoparticles deliver DNA-encoded biologics and induce potent protective immunity. Molecular Cancer. 24(1). 12–12. 2 indexed citations

Zhang, Mengmeng, Bingnan Guo, Xiaowei Zhang, et al.. (2025). IFP35, a novel DAMP, aggravates neuroinflammation following acute ischemic stroke via TLR4/NF-κB/NLRP3 signaling. Journal of Neuroinflammation. 22(1). 164–164. 5 indexed citations

Han, Lulu, Yuxin Chen, Nan Huang, et al.. (2024). Cancer-educated neutrophils promote lung cancer progression via PARP-1-ALOX5-mediated MMP-9 expression. Cancer Biology and Medicine. 21(2). 1–18. 7 indexed citations

Lu, Bowen, Liyuan Chai, Xin Jin, et al.. (2024). Co-immunization with IFI35 enhances the therapeutic effect of an adenovirus vaccine against renal carcinoma. International Journal of Biological Macromolecules. 286. 138515–138515.

Li, Wei, Junhao Wang, Dafei Chai, et al.. (2024). Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation. Blood. 145(10). 1047–1060. 2 indexed citations

Lu, Bowen, Siyuan Song, Praveen Neeli, et al.. (2024). The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects. Frontiers in Immunology. 15. 1332939–1332939. 69 indexed citations breakdown →

Zheng, Yanyan, Fei Zhu, Bowen Lu, et al.. (2024). Therapeutic vaccine targeting dual immune checkpoints induces potent multifunctional CD8+ T cell anti-tumor immunity. International Immunopharmacology. 142(Pt A). 113004–113004. 1 indexed citations

Sobhani, Navid, Dafei Chai, Daniele Generali, et al.. (2024). Artificial intelligence-powered discovery of small molecules inhibiting CTLA-4 in cancer. PubMed. 2(1). 13 indexed citations

Chai, Dafei, Junhao Wang, Chunmei Fan, et al.. (2024). Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant. Journal of Hematology & Oncology. 17(1). 45–45. 9 indexed citations

10.

Ding, Jiage, Fei Zhu, Navid Sobhani, et al.. (2023). The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma. npj Vaccines. 8(1). 109–109. 5 indexed citations

11.

Neeli, Praveen, Dafei Chai, Xu Wang, et al.. (2023). Comparison of DNA vaccines with AddaS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2. iScience. 26(7). 107120–107120. 8 indexed citations

12.

Tian, Hui, Dafei Chai, Gang Wang, et al.. (2023). Mitochondrial C1QBP is essential for T cell antitumor function by maintaining mitochondrial plasticity and metabolic fitness. Cancer Immunology Immunotherapy. 72(7). 2151–2168. 8 indexed citations

13.

Shi, Xiaoqing, Jiage Ding, Jiawei Wang, et al.. (2023). HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma. iScience. 26(3). 106143–106143. 12 indexed citations

14.

Sobhani, Navid, Bruna Scaggiante, Dafei Chai, et al.. (2022). Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials. Cancer Treatment Reviews. 109. 102429–102429. 58 indexed citations

15.

Chai, Dafei, Chen Zhang, Gang Wang, et al.. (2021). Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinoma. Translational Oncology. 14(4). 101018–101018. 19 indexed citations

16.

Li, Juan, Zengli Guo, Yuxin Chen, et al.. (2021). Co-immunizing with HMGB1 enhances anti-tumor immunity of B7H3 vaccine in renal carcinoma. Molecular Immunology. 139. 184–192. 7 indexed citations

17.

Chai, Dafei, Gang Wang, Huizhong Li, et al.. (2018). AIM2 is a potential therapeutic target in human renal carcinoma and suppresses its invasion and metastasis via enhancing autophagy induction. Experimental Cell Research. 370(2). 561–570. 40 indexed citations

18.

Yang, Jie, Hong Yin, Yanhong Wei, et al.. (2018). Tumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate Cancer. Translational Oncology. 12(3). 453–461. 10 indexed citations

19.

Luan, Yan, Dafei Chai, Min Wang, et al.. (2016). A fully human monoclonal antibody targeting PD-L1 with potent anti-tumor activity. International Immunopharmacology. 31. 248–256. 14 indexed citations

20.

Chai, Dafei, Yue Yan, Wei Xu, Chunsheng Dong, & Sidong Xiong. (2015). AIM2 co-immunization favors specific multifunctional CD8+ T cell induction and ameliorates coxsackievirus B3-induced chronic myocarditis. Antiviral Research. 119. 68–77. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact